Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study.

MLA

Zhu, Gui‐Qi, et al. “Serial Circulating Tumor DNA to Predict Early Recurrence in Patients with Hepatocellular Carcinoma: A Prospective Study.” Molecular Oncology, vol. 16, no. 2, Jan. 2022, pp. 549–61. EBSCOhost, https://doi.org/10.1002/1878-0261.13105.

APA

Zhu, G., Liu, W., Tang, Z., Qu, W., Fang, Y., Jiang, X., Song, S., Wang, H., Tao, C., Zhou, P., Huang, R., Gao, J., Sun, H., Ding, Z., Peng, Y., Dai, Z., Zhou, J., Fan, J., & Shi, Y. (2022). Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study. Molecular Oncology, 16(2), 549–561. https://doi.org/10.1002/1878-0261.13105

Chicago

Zhu, Gui‐Qi, Wei‐Ren Liu, Zheng Tang, Wei‐Feng Qu, Yuan Fang, Xi‐Fei Jiang, Shu‐Shu Song, et al. 2022. “Serial Circulating Tumor DNA to Predict Early Recurrence in Patients with Hepatocellular Carcinoma: A Prospective Study.” Molecular Oncology 16 (2): 549–61. doi:10.1002/1878-0261.13105.